PAX5 and hepatocellular carcinoma: In the present study, based on the evaluation of autoantibodies to PAX5, PTCH1, and GNA11 in Hispanic American subjects, the three autoantibodies have high diagnostic performances to identify HCC from NC with AUCs of 0.908, 0.913, and 0.924, respectively.